Teacher Retirement System of Texas Purchases 4,870 Shares of Chemed Co. (NYSE:CHE)

Teacher Retirement System of Texas grew its position in Chemed Co. (NYSE:CHEGet Rating) by 198.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,324 shares of the company’s stock after purchasing an additional 4,870 shares during the quarter. Teacher Retirement System of Texas’ holdings in Chemed were worth $3,197,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also modified their holdings of the company. Dark Forest Capital Management LP bought a new position in shares of Chemed in the second quarter worth approximately $34,000. Canada Pension Plan Investment Board bought a new position in shares of Chemed in the first quarter worth approximately $46,000. Wipfli Financial Advisors LLC bought a new position in shares of Chemed in the third quarter worth approximately $54,000. Venture Visionary Partners LLC bought a new position in shares of Chemed during the second quarter worth $68,000. Finally, Quantbot Technologies LP bought a new position in shares of Chemed during the first quarter worth $109,000. 91.12% of the stock is currently owned by institutional investors.

Insider Activity at Chemed

In related news, EVP Spencer S. Lee sold 2,000 shares of the company’s stock in a transaction on Tuesday, November 8th. The shares were sold at an average price of $490.09, for a total transaction of $980,180.00. Following the sale, the executive vice president now owns 22,701 shares of the company’s stock, valued at $11,125,533.09. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other news, EVP Spencer S. Lee sold 2,000 shares of the stock in a transaction on Tuesday, November 8th. The shares were sold at an average price of $490.09, for a total value of $980,180.00. Following the sale, the executive vice president now owns 22,701 shares of the company’s stock, valued at $11,125,533.09. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, VP Michael D. Witzeman sold 736 shares of the stock in a transaction on Thursday, November 10th. The shares were sold at an average price of $498.47, for a total transaction of $366,873.92. Following the completion of the sale, the vice president now directly owns 1,900 shares in the company, valued at approximately $947,093. The disclosure for this sale can be found here. Insiders have sold a total of 9,036 shares of company stock valued at $4,444,780 over the last 90 days. 4.03% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of equities analysts recently weighed in on CHE shares. Royal Bank of Canada upped their target price on shares of Chemed from $541.00 to $545.00 and gave the stock an “outperform” rating in a research report on Thursday, November 3rd. StockNews.com lowered shares of Chemed from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, November 9th.

Chemed Price Performance

Shares of NYSE:CHE opened at $493.23 on Wednesday. The firm has a market cap of $7.33 billion, a price-to-earnings ratio of 28.66, a P/E/G ratio of 3.52 and a beta of 0.55. The firm has a fifty day moving average price of $507.93 and a 200 day moving average price of $485.87. The company has a debt-to-equity ratio of 0.13, a quick ratio of 0.63 and a current ratio of 0.67. Chemed Co. has a fifty-two week low of $430.16 and a fifty-two week high of $528.72.

Chemed (NYSE:CHEGet Rating) last released its quarterly earnings results on Monday, October 31st. The company reported $4.74 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.61 by $0.13. The company had revenue of $526.47 million for the quarter, compared to the consensus estimate of $527.05 million. Chemed had a net margin of 12.31% and a return on equity of 44.29%. Chemed’s revenue was down 2.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $5.06 earnings per share. As a group, sell-side analysts expect that Chemed Co. will post 18.69 earnings per share for the current fiscal year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, December 5th. Investors of record on Monday, November 14th were paid a dividend of $0.38 per share. This represents a $1.52 dividend on an annualized basis and a yield of 0.31%. The ex-dividend date of this dividend was Thursday, November 10th. Chemed’s payout ratio is 8.83%.

Chemed Profile

(Get Rating)

Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the VITAS and Roto-Rooter segments. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.

Recommended Stories

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHEGet Rating).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.